Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 1/2 18Phase 1 17Phase 3 5Phase 4 3Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 3856Neoplasms 2988Prostatic Neoplasms 1751Colorectal Neoplasms 1426Lung Neoplasms 1327Motor Activity 802Head and Neck Neoplasms 683Pancreatic Neoplasms 662Colonic Neoplasms 655Uterine Cervical Neoplasms 648Carcinoma, Non-Small-Cell Lung 629Carcinoma, Hepatocellular 628Rectal Neoplasms 569Stomach Neoplasms 544Brain Neoplasms 483Ovarian Neoplasms 438Anxiety Disorders 419Pain 418Neoplasm Metastasis 385Esophageal Neoplasms 384Polycystic Ovary Syndrome 374Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Urinary Bladder Neoplasms 351Fatigue 339Melanoma 322Multiple Myeloma 320Lymphoma 305Depression 305Endometrial Neoplasms 289Liver Neoplasms 279

Interventions

Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Interventional × Immune System Diseases × Clear all
NCT04097067 2024-08-27

ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma

University Hospital Muenster

Phase NA Recruiting
83 enrolled
Lymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡